Krensavage Asset Management, LLC / REGN
Krensavage Asset Management, LLC’s Regeneron Pharmaceuticals Position
Does Krensavage Asset Management, LLC own Regeneron Pharmaceuticals (REGN)? Yes — 4.0K shares worth $3M (+1.21% of its 13F portfolio) as of Q1 2026.
Position Value
$3M
Q1 2026
Shares
4.0K
% of Portfolio
+1.21%
Quarters Held
24
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.0K | $3M | +1.21% |
| Q4 2025 | 4.0K | $3M | +1.09% |
| Q3 2025 | 4.0K | $2M | +0.96% |
| Q2 2025 | 4.0K | $2M | +1.11% |
| Q3 2024 | 353 | $371,000 | +0.21% |
| Q2 2024 | 7.9K | $8M | +3.79% |
| Q1 2024 | 12.5K | $12M | +5.33% |
| Q4 2023 | 47.3K | $42M | +14.73% |
| Q3 2023 | 47.3K | $39M | +14.32% |
| Q2 2023 | 59.2K | $43M | +13.47% |
| Q1 2023 | 59.5K | $49M | +14.84% |
| Q4 2022 | 60.1K | $43M | +13.40% |
| Q3 2022 | 60.9K | $42M | +13.36% |
| Q2 2022 | 60.4K | $36M | +11.80% |
| Q1 2022 | 66.9K | $47M | +16.10% |
| Q4 2021 | 69.1K | $44M | +15.13% |
| Q3 2021 | 73.1K | $44M | +13.89% |
| Q2 2021 | 82.1K | $46M | +15.57% |
| Q1 2021 | 82.7K | $39M | +13.54% |
| Q4 2020 | 82.2K | $40M | +11.60% |
| Q3 2020 | 82.3K | $46M | +14.66% |
| Q2 2020 | 79.7K | $50M | +13.52% |
| Q1 2020 | 86.8K | $42M | +13.64% |
| Q4 2019 | 104.4K | $39M | +13.38% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Krensavage Asset Management, LLC’s full portfolio or all institutional holders of REGN.